Position in NVS
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$15,672
+$397 QoQ
Shares Held
100
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,512
of 1,603 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Horrell Capital Management, Inc. holds $134,199 across 4 Drug Manufacturers - General names. NVS ranks #2 (11.7% of the industry book) .
All Filings in NVS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,672 | 100 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $15,275 | 100 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $13,787 | 100 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $12,824 | 100 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $12,101 | 100 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $11,148 | 100 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $9,731 | 100 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $11,502 | 100 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $10,646 | 100 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $9,673 | 100 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $10,097 | 100 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $10,186 | 100 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $10,091 | 100 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $9,200 | 100 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $9,072 | 100 | Shares | Sole | 2023-01-30 | |
| No filing history on record for this holder in this stock. | ||||||